Premier Asset Management’s Q32 Bio QTTB Stock Holding History

Premier Asset Management’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,284	Closed	-$871K	–	208
2020 Q4	$871K	Buy	+4,284	New	+$828K	0.18%	80

Other funds holding QTTB

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Premier Asset Management's QTTB Position: Q1 2021 in Review

Premier Asset Management sold out of Q32 Bio (QTTB) in Q1 2021, closing a stake of 4,284 shares — an estimated $871K sold.

Premier Asset Management first reported a position in QTTB in Q4 2020 and held it in 1 quarter. The position peaked at $871K in Q4 2020. 109 funds tracked by Wall St. Rank hold QTTB as of Q1 2021.

Premier Asset Management reported no remaining Q32 Bio position as of Q1 2021 after selling out during the quarter.
Premier Asset Management sold 4,284 Q32 Bio shares in Q1 2021, an estimated $871K.
Premier Asset Management first reported a position in Q32 Bio in Q4 2020 and held it in 1 quarter.
Premier Asset Management's Q32 Bio position peaked at $871K in Q4 2020.
109 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2021.

Based on Premier Asset Management's 13F filing for Q1 2021, filed 12 May 2021.